Xencor

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.

About XNCR

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. 

CEO
Bassil I. Dahiyat
CEOBassil I. Dahiyat
Employees
250
Employees250
Headquarters
Pasadena, California
HeadquartersPasadena, California
Founded
1997
Founded1997
Employees
250
Employees250

XNCR Key Statistics

Market cap
1.05B
Market cap1.05B
Price-Earnings ratio
-6.11
Price-Earnings ratio-6.11
Dividend yield
Dividend yield
Average volume
1.56M
Average volume1.56M
High today
$15.25
High today$15.25
Low today
$14.47
Low today$14.47
Open price
$14.85
Open price$14.85
Volume
1.94M
Volume1.94M
52 Week high
$27.24
52 Week high$27.24
52 Week low
$6.92
52 Week low$6.92

XNCR News

Simply Wall St 10h
A Look at Xencor's Valuation After 60% Rally This Month

Xencor (XNCR) shares have moved nearly 60% higher over the past month, catching the attention of investors interested in biotechnology stocks with a turnaround...

A Look at Xencor's Valuation After 60% Rally This Month
TipRanks 5d
Xencor price target raised to $14 from $12 at BofA

BofA raised the firm’s price target on Xencor (XNCR) to $14 from $12 and keeps a Neutral rating on the shares. Initial data for XmAb819, Xencor’s T-cell engager...

Analyst ratings

85%

of 13 ratings
Buy
84.6%
Hold
7.7%
Sell
7.7%

People also own

Based on the portfolios of people who own XNCR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.